来自CEPAM队列的他莫西芬治疗患者中Z-恩多西芬度的非线性混合效应模型
Anna M Mc Laughlin1,2, Thomas Helland3,4,5, Fenja Klima1,2
1Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany.
这项研究确定了Z-内西芬度值,用于在乳腺癌患者中确定他莫西芬的疗效. 使用超过6000名患者的药量计模型有助于个性化他莫西芬治疗,以获得更好的结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 塔莫西芬对于激素受体阳性乳腺癌至关重要.
- 酶CYP2D6的活性显著影响着他莫西芬的活性代谢物Z-endoxifen,导致治疗的变化.
- 确定Z-内西芬度值来确定他莫西芬的有效性至关重要,但具有挑战性.
研究的目的:
- 为了验证Z-内西芬水平与他莫西芬治疗有效性之间的联系.
- 为了确定Z-内西芬度值,表明他莫西芬的疗效.
- 利用药量计模型和模拟用于个性化他莫西芬治疗.
主要方法:
- 开发了一个非线性混合效应 (NLME) 模型,使用28项研究中超过7,000名患者的数据 (清洗后6083名患者).
- 综合数据测量了总氧和Z-氧的度.
- 模拟的塔莫西芬和Z-恩多西芬的药理动力学,考虑到CYP2D6,体重,CYP2C9和CYP2D6抑制剂的联合治疗.
主要成果:
- NLME模型证实了CYP2D6在Z-氧的药理动力学中的中心作用.
- 确定了体重,CYP2C9表型和CYP2D6抑制剂的同时使用药物作为影响Z-endoxifen水平的重要因素.
- 开发的模型为未来的模拟提供了基础,以确定疗效值.
结论:
- 开发的药量测量模型准确地描述了塔莫西芬和Z-恩多西芬的药理动力学.
- 未来使用该模型的模拟将确定Z-内西芬度值,以确定他莫西芬的有效性.
- 这项研究为个性化他莫西芬治疗策略铺平了道路,以提高乳腺癌患者的治疗结果.
更多相关视频
06:46Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development
Published on: September 4, 2021
12:02Using TgVtg1:mcherry Zebrafish Embryos to Test the Estrogenic Effects of Endocrine Disrupting Compounds
Published on: August 8, 2020
相关概念视频
Time Course of Drug Effect
Three-Compartment Open Model
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Analysis of Population Pharmacokinetic Data
Compartment Models: Two-Compartment Model
